COVID-19-associated acute respiratory distress syndrome (C-ARDS): Inhaled nitroglycerin could be an efficient pulmonary vasodilator.
作者信息
Daunaria Deepak K, Singh Girish K, Agarwal Ankit, Mishra Priyanka
机构信息
Department of Anaesthesiology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Department of Anaesthesiology and Critical Care, Shri Guru Ram Rai Institute of Medical and Health Sciences, Dehradun, Uttarakhand, India.
出版信息
Indian J Anaesth. 2023 Apr;67(4):403-405. doi: 10.4103/ija.ija_635_22. Epub 2023 Apr 10.
Abstract
摘要
相似文献
1
COVID-19-associated acute respiratory distress syndrome (C-ARDS): Inhaled nitroglycerin could be an efficient pulmonary vasodilator.
Indian J Anaesth. 2023 Apr;67(4):403-405. doi: 10.4103/ija.ija_635_22. Epub 2023 Apr 10.
2
COVID-19 Acute Respiratory Distress Syndrome and Pulmonary Embolism: A Case Report of Nebulized Nitroglycerin and Systemic Thrombolysis For Right Ventricular Failure.
J Emerg Med. 2021 Nov;61(5):e103-e107. doi: 10.1016/j.jemermed.2021.07.014. Epub 2021 Jul 9.
3
Are inhaled vasodilators useful in acute lung injury and acute respiratory distress syndrome?
Respir Care. 2010 Feb;55(2):144-57; discussion 157-61.
4
Inhaled Nitric Oxide for Clinical Management of COVID-19: A Systematic Review and Meta-Analysis.
Int J Environ Res Public Health. 2022 Oct 6;19(19):12803. doi: 10.3390/ijerph191912803.
5
A Comparison of Inhaled Epoprostenol in Patients With Acute Respiratory Distress Syndrome and COVID-19-Associated Acute Respiratory Distress Syndrome.
Cureus. 2022 Aug 22;14(8):e28274. doi: 10.7759/cureus.28274. eCollection 2022 Aug.
6
Evaluation of Continuous Inhaled Epoprostenol in the Treatment of Acute Respiratory Distress Syndrome, Including Patients With SARS-CoV-2 Infection.
Ann Pharmacother. 2022 Oct;56(10):1093-1099. doi: 10.1177/10600280211069182. Epub 2022 Jan 13.
7
Inhaled Prostacyclins for Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis.
Crit Care Explor. 2023 Jun 8;5(6):e0931. doi: 10.1097/CCE.0000000000000931. eCollection 2023 Jun.
8
The role of inhaled prostacyclin in treating acute respiratory distress syndrome.
Ther Adv Respir Dis. 2015 Dec;9(6):302-12. doi: 10.1177/1753465815599345. Epub 2015 Aug 20.
9
COVID-19-associated acute respiratory distress syndrome versus classical acute respiratory distress syndrome (a narrative review).
Iran J Microbiol. 2021 Dec;13(6):737-747. doi: 10.18502/ijm.v13i6.8072.
10
Effects of rescue inhaled nitric oxide on right ventricle and pulmonary circulation in severe COVID-related acute respiratory distress syndrome.
J Crit Care. 2022 Dec;72:153987. doi: 10.1016/j.jcrc.2022.153987. Epub 2022 Feb 2.
本文引用的文献
1
Nebulized Nitroglycerin for Coronavirus Disease 2019-Associated Acute Respiratory Distress Syndrome: A Case Report.
A A Pract. 2021 Feb 5;15(2):e01376. doi: 10.1213/XAA.0000000000001376.
2
Society of Onco-Anesthesia and Perioperative Care (SOAPC) advisory regarding perioperative management of onco-surgeries during COVID-19 pandemic.
Indian J Anaesth. 2020 May;64(Suppl 2):S97-S102. doi: 10.4103/ija.IJA_447_20. Epub 2020 May 23.
3
Aerosolized Vasodilators for the Treatment of Pulmonary Hypertension in Cardiac Surgical Patients: A Systematic Review and Meta-analysis.
Anesth Analg. 2017 Aug;125(2):393-402. doi: 10.1213/ANE.0000000000002138.
4
Effect of nitroglycerin inhalation on patients with pulmonary hypertension undergoing mitral valve replacement surgery.
Anesthesiology. 2003 Oct;99(4):855-8. doi: 10.1097/00000542-200310000-00017.
5
Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome.
Eur Respir J. 2003 Apr;21(4):720-7. doi: 10.1183/09031936.03.00120102.
6
Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery.
Anesth Analg. 1999 Nov;89(5):1108-15.
Zotero 插件